19:15:54 EST Thu 06 Nov 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:HBP - HELIX BIOPHARMA CORP. - https://www.helixbiopharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HBP - T  0.41.96·2.101.02.03+0.031.51.12152.00  2.10  2.005.40  0.5015:18:21Oct 2915 min RT 2¢
TSX - T0.41.96·2.101.02.03+0.031.50.7152.00  2.06  2.005.40  0.5015:18:2115 min
CX2 - H 2.06+0.063.00.1012.06  2.06  2.0614:11:0015 min
CXD - D 2.000.0062    Nov 0415 min
TriAct - M 2.000.105    Sep 01/2015 min
Lynx - Y 2.10+0.105.00.1012.10  2.10  2.1009:34:2015 min
CS2 - S 2.000.0501    15 min

Recent Trades - Last 10 of 15
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:58:00M2.030.03752 RBC1 AnonymousE
15:34:58M2.030.031580 National Bank1 AnonymousE
15:18:21T2.030.032002 RBC79 CIBCK
14:38:51M2.090.09580 National Bank80 National BankE
14:11:00H2.060.0610014 Virtu ITG79 CIBCK
14:11:00T2.060.0610014 Virtu ITG79 CIBCK
14:05:56M2.060.06102 RBC1 AnonymousE
13:41:01M2.060.06182 RBC7 TD SecE
09:34:20S2.100.105019 Desjardins7 TD SecE
09:34:20Y2.100.1010019 Desjardins1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-10-29 13:52C:HBP2.09SEDAR Annual Information FormSEDAR Annual Information Form
2025-10-29 12:45C:HBP2.09News ReleaseHelix BioPharma Corp. Announces Fiscal 2025 Year-End Results
2025-10-29 11:53C:HBP2.09SEDAR MD & ASEDAR MD & A
2025-10-29 11:48C:HBP2.09SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-10-06 21:39C:HBP5.31News ReleaseHelix BioPharma does not say why trading is up
2025-09-09 16:15C:HBP1.48News ReleaseHelix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025
2025-09-05 18:54C:HBP1.45News ReleaseHelix ends review, drops GEM equity facility plan
2025-08-22 18:27C:HBP1.35News ReleaseHelix BioPharma closes $1.66-million private placement
2025-08-13 19:29C:HBP1.12News ReleaseHelix publishes article in Frontiers in Oncology
2025-06-16 19:00C:HBP0.91News ReleaseHelix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 2025
2025-06-16 16:36C:HBP0.91SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-06-16 16:36C:HBP0.91SEDAR Interim MD & ASEDAR Interim MD & A
2025-06-02 20:45C:HBP0.92News ReleaseHelix BioPharma appoints Babbar as CFO
2025-05-20 18:31C:HBP0.95News ReleaseHelix BioPharma closes acquisitions of Laevoroc assets
2025-05-14 19:43C:HBP0.96News ReleaseHelix BioPharma signs capital raising agreement
2025-04-24 17:58C:HBP0.78News ReleaseHelix Bio appoints Kandziora, Kourniaktis as execs
2025-04-10 17:57C:HBP0.79News ReleaseHelix BioPharma promotes Mehrling to CEO
2025-04-03 17:30C:HBP0.79News ReleaseHelix BioPharma hires ITG for market-making services
2025-03-26 18:19C:HBP0.80News ReleaseHelix BioPharma holders approve all matters at AGSM